Innovation Wrap: Synthetic cornea implants, unsolved murders in VR, and dire wolf DNA
Thomas Rice, portfolio manager for the Perpetual Global Innovation Share Fund provides your weekly wrap of technology, innovation, and finance news.
Published on February 1, 2021
By
Thomas Rice
Greetings!
Here’s your wrap of the latest technology, innovation, and finance news.
? Health
Korean researchers have come up with a way to diagnose prostate cancer with just a urine test, 20 minutes, and a splash of AI. The new technique boasts an accuracy rate of almost 100% (see the paper).
A 78-year old blind man in Israel became the first recipient of a new type of synthetic cornea implant called the CorNet KPro, which restored his sight.
Developed by a company called CorNeat, the KPro is the first implant that can be integrated directly into the eye wall to replace scarred or deformed corneas with no donor tissue. Immediately after the surgery, the patient was able to recognize family members and read numbers on an eye chart.
? Mouse Health
The scientists who helped develop Pfizer’s COVID-19 vaccine have used the same technology to develop a vaccine that they say cures multiple sclerosis in mice, taking us one step closer to a cure for humans.
BioNTech CEO Ugur Sahin led research showing that an mRNA vaccine might also work in multiple sclerosis, Fierce Biotech, a pharma news outlet, reported.
Sahin’s team showed that an mRNA vaccine encoding a disease-related autoantigen successfully improved MS symptoms in sick animals and prevented disease progression in rodents showing early signs of MS.
“The most interesting thing that they were able to show is that the macrophages are causal in driving age-associated cognitive decline, and, in particular, that it’s sufficient to reprogram the macrophages outside of the brain,” says Jonas Neher, a neuroimmunologist at the German Center for Neurodegenerative Diseases and the University of Tübingen in Germany who authored an accompanying commentary.
The team tested ION251 on these myeloma mouse avatars. Compared to untreated mice, the treated mice had significantly fewer myeloma cells after two to six weeks of treatment. What’s more, 70 to 100 percent of the treated mice survived, whereas none of the untreated control mice did.
? Artificial Intelligence
OpenAI showcased DALL-E, an impressive neutral network that creates images from text captions. Below are images generated from the text prompt “A snail made from a harp. A snail with the texture of a harp.”
Post Views:12
Serving up fresh finance news, marker movers & expertise.